These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 240472)

  • 1. The effects of tetraphenylboron on spontaneous transmitter release at the frog neuromuscular junction.
    Marshall IG; Parsons RL
    Br J Pharmacol; 1975 Jul; 54(3):333-8. PubMed ID: 240472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of tetraphenylboron on neuromuscular transmission in the frog.
    Marshall IG; Parsons RL
    Br J Pharmacol; 1975 Jul; 54(3):325-32. PubMed ID: 169931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lanthanum as a surrogate for calcium in transmitter release at mouse motor nerve terminals.
    Curtis MJ; Quastel DM; Saint DA
    J Physiol; 1986 Apr; 373():243-60. PubMed ID: 2875177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lithium ions and the release of transmitter at the frog neuromuscular junction.
    Crawford AC
    J Physiol; 1975 Mar; 246(1):109-42. PubMed ID: 237119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of calcium ions on bimodal parameters of mediator liberation in frog sartorius muscle neuromuscular junctions].
    Zefirov AL
    Fiziol Zh SSSR Im I M Sechenova; 1980 Apr; 66(4):531-6. PubMed ID: 6104608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modification by lithium of transmitter release at the neuromuscular junction of the frog.
    Branisteanu DD; Volle RL
    J Pharmacol Exp Ther; 1975 Aug; 194(2):362-72. PubMed ID: 239225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temperature-sensitive aspects of evoked and spontaneous transmitter release at the frog neuromuscular junction.
    Barrett EF; Barrett JN; Botz D; Chang DB; Mahaffey D
    J Physiol; 1978 Jun; 279():253-73. PubMed ID: 209175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zn2+ stimulates spontaneous transmitter release at mouse neuromuscular junctions.
    Nishimura M
    Br J Pharmacol; 1988 Feb; 93(2):430-6. PubMed ID: 2896035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The action of lindane in accelerating the spontaneous release of transmitter at the frog neuromuscular junction.
    Publicover SJ; Duncan CJ
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Aug; 308(2):179-82. PubMed ID: 91977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of phorbol ester on spontaneous transmitter release at frog neuromuscular junction.
    Eusebi F; Molinaro M; Caratsch CG
    Pflugers Arch; 1986 Feb; 406(2):181-3. PubMed ID: 2870468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The action of verapamil on the rate of spontaneous release of transmitter at the frog neuromuscular junction.
    Publicover SJ; Duncan CJ
    Eur J Pharmacol; 1979 Feb; 54(1-2):119-27. PubMed ID: 33814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-uniform responses to Ca2+ along the frog neuromuscular junction: effects on the probability of spontaneous and evoked transmitter release.
    Robitaille R; Tremblay JP
    Neuroscience; 1991; 40(2):571-85. PubMed ID: 1674115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ryanodine facilitates calcium-dependent release of transmitter at mouse neuromuscular junctions.
    Nishimura M; Tsubaki K; Yagasaki O; Ito K
    Br J Pharmacol; 1990 May; 100(1):114-8. PubMed ID: 1973623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depletion of synaptic vesicles at the frog (Rana pipiens) neuromuscular junctions by tetraphenylboron.
    Marshall IG; Parsons RL; Paull WK
    Experientia; 1976 Nov; 32(11):1423-6. PubMed ID: 1086796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of botulinum toxin on neuromuscular transmission in the rat.
    Cull-Candy SG; Lundh H; Thesleff S
    J Physiol; 1976 Aug; 260(1):177-203. PubMed ID: 184273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the release of transmitter at normal, myasthenia gravis and myasthenic syndrome affected human end-plates.
    Cull-Candy SG; Miledi R; Trautmann A; Uchitel OD
    J Physiol; 1980 Feb; 299():621-38. PubMed ID: 6103954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of 4-aminopyridine at the frog neuromuscular junction.
    Molgo J; Lemeignan M; Lechat P
    J Pharmacol Exp Ther; 1977 Dec; 203(3):653-63. PubMed ID: 21957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Equivalence of Ca2+ and Sr2+ in transmitter release from K+-depolarised nerve terminals.
    Mellow AM
    Nature; 1979 Nov; 282(5734):84-5. PubMed ID: 41184
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of 4-aminopyridine on neuromuscular transmission.
    Lundh H
    Brain Res; 1978 Sep; 153(2):307-18. PubMed ID: 210882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual action of ouabain on transmitter release at neuromuscular junctions of the frog.
    Brănişteanu DD; Proca B; Haulică ID
    J Pharmacol Exp Ther; 1979 Apr; 209(1):31-6. PubMed ID: 34716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.